Detalhe da pesquisa
1.
Overexpression of KIR inhibitory ligands (HLA-I) determines that immunosurveillance of myeloma depends on diverse and strong NK cell licensing.
Oncoimmunology
; 5(4): e1093721, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27141379